BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Warp Drive Bio  

400 Technology Square

Cambridge  Massachusetts  02139  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS

Warp Drive Bio is driving the reemergence of natural products in the era of genomics to create breakthrough treatments that make an important difference in the lives of patients. Built upon the belief that nature is the world’s most powerful medicinal chemist, Warp Drive Bio is deploying a battery of state-of-the-art technologies to access powerful drugs that are now hidden within microbes.

Several major technological developments have recently enabled an entirely new approach to natural product drug discovery. This newly opened window into nature’s vast portfolio of genetically encoded but unexpressed drugs stems from the convergence of multiple advances in disparate fields. Notably, these advances include the discovery that natural product biosynthetic genes are clustered, the development of ultra high-throughput DNA sequencing technology that can acquire enormous amounts of genomic information cost-effectively, and the emergence of bio-informatic and chemo-informatic capabilities that can convert raw DNA sequence into accurate structural predictions of encoded natural products.

These, together with biophysical insights into natural product mechanisms of action, have allowed Warp Drive Bio to identify what we call “chemomemes,” conserved structural domains that define important classes of natural products. The encoding of chemomemes by conserved genetic elements within biosynthetic gene clusters provides the basis for a search through genomic space to identify novel molecules containing a particular chemomeme.

Key to the Warp Drive Bio approach is the company’s proprietary “genomic search engine” and customized search queries that enable hidden natural products to be revealed on the basis of their distinctive genomic signature. We are focusing this innovative search engine on chemomemes having high pharmaceutical pedigree, novel and profound biological effects that tap into areas of high unmet medical need, and the ability to access targets that abiotic small molecules and monoclonal antibodies cannot. These molecules will have already been evolved by nature to possess excellent pharmaceutical properties and compelling mechanisms of action, factors that will greatly accelerate the timeline to clinical entry.

The Warp Drive Bio technology platform is built around the “3Rs” suite of capabilities, creating an integrated drug discovery process that converts genomes to drugs. The first R, Reading, brings to bear state-of-the-art genomic data acquisition technologies plus our proprietary search engine to discovery potentially high-value biosynthetic gene clusters nested within bacterial genomes. Gene clusters of high interest identified via Reading are then funneled into the second R, wRiting, which configures the biosynthetic gene clusters of interest for engineered over-production and provides the encoded natural product in pure form and in multi-milligram quantities for structural and functional studies. Finally, the third R, aRithmetic, provides mechanistic insight into the function of our novel natural products via high-throughput cellular target identification and subsequent characterization of phenotypic and molecular effects.

Launched in 2011 through a groundbreaking strategic partnership with Sanofi and with financing from Third Rock Ventures and Greylock Partners, the company was founded by renowned scientist Dr. Gregory Verdine, along with Dr. George Church and Dr. James Wells.



 Key Statistics


Email: Info@warpdrivebio.com
Ownership: Private

Web Site: Warp Drive Bio
Employees: 15
Symbol: 
 



Industry
Biotechnology






 Company News
Harvard University Professor Steps Down to Pilot Warp Drive Bio 7/2/2013 6:16:36 AM    More...
Sanofi (France) (SAN.PA) to Seek More Venture-Capital Deals Like Warp Drive Bio 3/25/2013 8:10:57 AM    More...

//-->